Treatment with acetyl-L-carnitine has the potential to improve the clinical course of painful peripheral neuropathies in HIV-positives patients.
Famularo
G
G
De Simone
C
C
D000108:Acetylcarnitine / Q000627:therapeutic use*; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy* / Q000209:etiology*
D000108:Acetylcarnitine